Alexion Pharmaceuticals, Inc.
All Topics
Find news about people
Find news on alumni of any org
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed
Alexion Pharmaceuticals, Inc.
... Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the submission of a Biologics License Application (BLA) ...
... typical trends and are particularly focused on rare diseases, such as the Alexion Pharmaceuticals. In these ways mid-size companies can be seen to be different ...
... in phase 3. Elsewhere, Dutch biotech Complement Pharma struck a deal with Alexion. Targovax tumbled after rethinking its pancreatic cancer plans. Ipsen chose Kendall Square ...
... Alexion has secured the option to acquire Dutch biotech Complement Pharma. The agreement ...
... BridgeBio Pharmatoday announced that it has entered into an agreement with Alexion Pharmaceuticals, Inc. to acquire cyclic pyranopterin monophosphate (cPMP; ALXN1101), a synthetic enzyme co-factor ...
... Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Complement Pharma today announced a partnership to co-develop the ...
... Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the Goldman Sachs ...
... Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that its offer, through a wholly owned subsidiary, ...
Subscribe now for full coverage on Alexion Pharmaceuticals, Inc.
Start My Free Trial